The Next Frontier in Food Biotechnology: the Gene-Edited PRRS-Resistant Pig

In a milestone decision, FDA recently approved development and commercialization of a gene-edited PRRS-Resistant Pig. Positive regulatory determinations have already been received in Columbia, Brazil, and Dominican Republic. Join the FMI Foundation for a discussion of market implications, commercialization timelines, and consumer information resources regarding this new development in food biotechnology. The webinar, free to FMI members, will feature Banks Baker, Senior Director, New Product Strategy for Pig Improvement Company (PIC), North America. 

REGISTER/PURCHASE

FMI Members will be redirected to FMI's online store to complete your $0.00 purchase, then can return to this page to access the live presentation.